Mylan biosimilar application moves forward

26-08-2016

Mylan biosimilar application moves forward

blackboard1965 / Shutterstock.com

The European Medicines Agency has accepted pharmaceutical company Mylans request to review its application for a biosimilar of Herceptin (trastuzumab).


Mylan, Biocon, EMA, MAA, Trastuzumab

LSIPR